Richard Marais

Prodrugs of protein tyrosine kinase inhibitors

Pyrido[2,3-B]pyrazin-8-substituted compounds and their use

Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy

Surface expression of enzyme in gene directed prodrug therapy

Improvements relating to prodrugs

1 -(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4h-pyrido[2, 3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as raf inhibitors for the treatment of cancer

1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy

Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy

Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system

IMIDAZO[4,5-B]PYRIDIN-2-ONE AND OXAZOLO[4,5-B]PYRIDIN-2-ONE COMPOUNDS AND ANALOGS THEREOF AS THERAPEUTIC COMPOUNDS [45-B]-2-[45-B]-2-